Literature DB >> 21778118

Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome.

Abhishek Chandra1, Norman Latov, Gary P Wormser, Adriana R Marques, Armin Alaedini.   

Abstract

The VlsE lipoprotein of Borrelia burgdorferi elicits a strong immune response during the course of Lyme disease. The present study was aimed at characterization of the epitopes of VlsE targeted by the antibody response in patients with post-Lyme disease syndrome, a condition characterized by persisting symptoms of pain, fatigue, and/or neurocognitive impairment despite antibiotic treatment of B. burgdorferi infection. Epitope mapping was carried out using microarrays that contained synthesized overlapping peptides covering the full sequence of VlsE from B. burgdorferi B31. In addition to the previously characterized IR6 region in the variable domain, specific sequences in the N- and C-terminal invariable domains of VlsE were found to be major B cell epitopes in affected patients. The crystal structure of VlsE indicated that the newly described epitopes form a contiguous region in the surface-exposed membrane-proximal part of the monomeric form of the protein.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778118      PMCID: PMC3183344          DOI: 10.1016/j.clim.2011.06.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  28 in total

1.  Crystal structure of Lyme disease variable surface antigen VlsE of Borrelia burgdorferi.

Authors:  Christoph Eicken; Vivek Sharma; Thomas Klabunde; Matthew B Lawrenz; John M Hardham; Steven J Norris; James C Sacchettini
Journal:  J Biol Chem       Date:  2002-03-28       Impact factor: 5.157

Review 2.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

3.  Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes.

Authors:  J R Zhang; J M Hardham; A G Barbour; S J Norris
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.

Authors:  Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

5.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

Review 6.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

7.  Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis.

Authors:  R V Fleming; A R Marques; M S Klempner; C H Schmid; L G Dally; D S Martin; M T Philipp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-07-08       Impact factor: 3.267

8.  An antibody which binds to the membrane-proximal end of influenza virus haemagglutinin (H3 subtype) inhibits the low-pH-induced conformational change and cell-cell fusion but does not neutralize virus.

Authors:  P Vanlandschoot; E Beirnaert; B Barrère; L Calder; B Millar; S Wharton; W M Jou; W Fiers
Journal:  J Gen Virol       Date:  1998-07       Impact factor: 3.891

9.  Dominant epitopes of the C6 diagnostic peptide of Borrelia burgdorferi are largely inaccessible to antibody on the parent VlsE molecule.

Authors:  Monica E Embers; Mary B Jacobs; Barbara J B Johnson; Mario T Philipp
Journal:  Clin Vaccine Immunol       Date:  2007-06-13

10.  Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.

Authors:  L B Krupp; L G Hyman; R Grimson; P K Coyle; P Melville; S Ahnn; R Dattwyler; B Chandler
Journal:  Neurology       Date:  2003-06-24       Impact factor: 9.910

View more
  14 in total

Review 1.  The Past, Present, and (Possible) Future of Serologic Testing for Lyme Disease.

Authors:  Elitza S Theel
Journal:  J Clin Microbiol       Date:  2016-02-10       Impact factor: 5.948

Review 2.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

3.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

4.  Increased IFNα activity and differential antibody response in patients with a history of Lyme disease and persistent cognitive deficits.

Authors:  Elzbieta Jacek; Brian A Fallon; Abhishek Chandra; Mary K Crow; Gary P Wormser; Armin Alaedini
Journal:  J Neuroimmunol       Date:  2012-11-08       Impact factor: 3.478

5.  Epitope-Specific Evolution of Human B Cell Responses to Borrelia burgdorferi VlsE Protein from Early to Late Stages of Lyme Disease.

Authors:  Elzbieta Jacek; Kevin S Tang; Lars Komorowski; Mary Ajamian; Christian Probst; Brian Stevenson; Gary P Wormser; Adriana R Marques; Armin Alaedini
Journal:  J Immunol       Date:  2015-12-30       Impact factor: 5.422

6.  A Multiplexed Serologic Test for Diagnosis of Lyme Disease for Point-of-Care Use.

Authors:  Siddarth Arumugam; Samiksha Nayak; Taylor Williams; Francesco Serra di Santa Maria; Mariana Soares Guedes; Rodrigo Cotrim Chaves; Vincent Linder; Adriana R Marques; Elizabeth J Horn; Susan J Wong; Samuel K Sia; Maria Gomes-Solecki
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

7.  New Zealand White Rabbits Effectively Clear Borrelia burgdorferi B31 despite the Bacterium's Functional vlsE Antigenic Variation System.

Authors:  Maliha Batool; Andrew E Hillhouse; Yurij Ionov; Kelli J Kochan; Fatemeh Mohebbi; George Stoica; David W Threadgill; Alex Zelikovsky; Suryakant D Waghela; Dominique J Wiener; Artem S Rogovskyy
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

8.  Development of a Multiantigen Panel for Improved Detection of Borrelia burgdorferi Infection in Early Lyme Disease.

Authors:  Lauren J Lahey; Michael W Panas; Rong Mao; Michelle Delanoy; John J Flanagan; Steven R Binder; Alison W Rebman; Jose G Montoya; Mark J Soloski; Allen C Steere; Raymond J Dattwyler; Paul M Arnaboldi; John N Aucott; William H Robinson
Journal:  J Clin Microbiol       Date:  2015-10-07       Impact factor: 5.948

9.  Serologic markers of Lyme disease in children with autism.

Authors:  Mary Ajamian; Barry E Kosofsky; Gary P Wormser; Anjali M Rajadhyaksha; Armin Alaedini
Journal:  JAMA       Date:  2013-05-01       Impact factor: 56.272

Review 10.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.